Key facts
- This page summarizes Robert Ticktin's Form 4 filing for PMV Pharmaceuticals, Inc. (PMVP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 03 Jul 2025, 19:51.
Robert Ticktin - 01 Jul 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)
- Signature
- /s/ Robert Ticktin
- Issuer symbol
- PMVP
- Transactions as of
- 01 Jul 2025
- Net transaction value
- -$24,651
- Form type
- 4
- Filing time
- 03 Jul 2025, 19:51:53 UTC
- Previous filing
- 23 Apr 2025
- Next filing
- 09 Mar 2026
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Robert Ticktin filed Form 4 for PMV Pharmaceuticals, Inc. (PMVP) on 03 Jul 2025.
Change
- Previous filing in this sequence was filed on 23 Apr 2025.
- Current net transaction value: -$24,651.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001613482
Primary reporting owner
Ticktin Robert
- Relationship
- General Counsel & COO
- Address
- C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON
- Signature
- /s/ Robert Ticktin
- Signature date
- 03 Jul 2025
Reported transactions
PMVP
transaction
Common Stock
Sale
- Transaction value
- $24,651
- Shares
- -23,151
- Change %
- -19%
- Price
- $1.06
- Shares after
- 98,695
- Date
- 01 Jul 2025
- Ownership
- Direct
- Footnotes
- F1, F2
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs. |
| F2 | Includes 15,528 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2025. |